Preventive Strategies in Epithelial Ovarian Cancer

QR Code

Preventive Strategies in Epithelial Ovarian Cancer

None

Saved in:

Bibliographic Details
Main Authors:	Mantia-Smaldone, Gina M., Scholler, Nathalie
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2012
Subjects:	Health Sciences
Online Access:	https://www.intechopen.com/chapters/28503
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Central Nervous System Involvement from Epithelial Ovarian Cancer
by: Cormio, Gennaro, et al.
Published: (2012)

Therapeutic Strategies in Ovarian Cancer
by: Ancuşa, Dan, et al.
Published: (2012)

Sensitive Detection of Epithelial Ovarian Cancer Biomarkers Using Tag-Laser Induced Breakdown Spectroscopy
by: Markushin, Yuri, et al.
Published: (2012)

Ectoenzymes in Epithelial Ovarian Carcinoma: Potential Diagnostic Markers and Therapeutic Targets
by: Buono, Nicola Lo, et al.
Published: (2012)

Antiprogestins in Ovarian Cancer
by: Telleria, Carlos M., et al.
Published: (2012)

Inflammation and Ovarian Cancer
by: Macciò, Antonio, et al.
Published: (2012)

Prevention and Therapeutic Strategies in Endometrial Cancer
by: Ancuşa, Dan, et al.
Published: (2012)

The impact of homologous recombination deficiency on the prognosis of epithelial ovarian cancer
by: Haiqi Su, et al.
Published: (2025-01-01)

Screening for Ovarian Cancer in Women
by: Thanapprapasr, Duangmani, et al.
Published: (2012)

Peripheral Neuropathy in Ovarian Cancer
by: Pan, Yi
Published: (2012)

Epidemiology and Etiology of Ovarian Cancer
by: Montes, Ana Fernández, et al.
Published: (2012)

Apoptosis Pathways in Ovarian Cancer
by: Sers, Christine, et al.
Published: (2012)

Neoadjuvant Chemotherapy in Ovarian Cancer
by: Singh, Jasmeet Chadha, et al.
Published: (2012)

Steroid Hormones and Ovarian Cancer
by: King, Erin R., et al.
Published: (2011)

Second-Line Chemotherapy for Platinum- and Taxane-Resistant Epithelial Ovarian Cancer: Pegylated Liposomal Doxorubicin (PLD), Irinotecan, and Combination Therapies at Lower Doses
by: Sugiyama, Toru
Published: (2012)

Epithelial-Mesenchymal Interactions in Oral Cancer Metastasis
by: Papagerakis, Silvana, et al.
Published: (2012)

Epithelial-Mesenchymal Transition and Cancer Stem Cells
by: Ouyang, Gaoliang
Published: (2011)

Management of Recurrent or Persistent Ovarian Cancer
by: Gennatas, Constantine
Published: (2012)

Sexuality After Ovarian Cancer Therapy
by: Farthmann, Juliane, et al.
Published: (2012)

Quality of Life of Patients with Ovarian Cancer
by: Chie, Wei-Chu, et al.
Published: (2012)

MALDI-MSI and Ovarian Cancer Biomarkers
by: Longuespee, Rémi, et al.
Published: (2012)

Dysregulated TGFB Signaling in Ovarian Cancer
by: Bauckman, Kyle, et al.
Published: (2012)

Potential Tumor Biomarkers for Ovarian Cancer
by: Serio, Ryan, et al.
Published: (2012)

P53 Network in Ovarian Cancer
by: Moretti, Fabiola, et al.
Published: (2012)

VEGF Targeting Agents in Ovarian Cancer
by: Mabuchi, Seiji, et al.
Published: (2012)

Endocrine Resistance and Epithelial Mesenchymal Transition in Breast Cancer
by: Saleh, Sanaa Al, et al.
Published: (2011)

Ovarian Cancer Incidence: Current and Comprehensive Statistics
by: Stewart, Sherri L.
Published: (2012)

Strategies for the Prevention of Meningitis
by: Stoddard, J.J., et al.
Published: (2012)

CXCL11 mediates TWIST1-induced angiogenesis in epithelial ovarian cancer
by: Yu-Jin Koo, et al.
Published: (2017-05-01)

The transcription factor FOXA1 induces epithelial ovarian cancer tumorigenesis and progression
by: Li-Li Wang, et al.
Published: (2017-05-01)

Predicting the prognosis of epithelial ovarian cancer patients based on deep learning models
by: Zihan Li, et al.
Published: (2025-07-01)

HER2 as a Therapeutic Target in Ovarian Cancer
by: Amler, Lukas C., et al.
Published: (2012)

Endometriosis-Associated Ovarian Cancer: The Role of Oxidative Stress
by: Yamashita, Yoriko, et al.
Published: (2012)

Potential Monoclonal Antibody Therapy for the Treatment of Ovarian Cancer
by: Lee, Gregory, et al.
Published: (2012)

Expression of selected epithelial–mesenchymal transition transcription factors in serous borderline ovarian tumors and type I ovarian cancers
by: Pawel Sadlecki, et al.
Published: (2018-06-01)

Autotaxin – A Target for the Treatment of Drug-Resistant Ovarian Cancer?
by: King-Underwood, John, et al.
Published: (2012)

Mass spectrometric profiling reveals association of -glycan patterns with epithelial ovarian cancer progression
by: Huanhuan Chen, et al.
Published: (2017-07-01)

Association of a common variant of gene with increased risk of serous epithelial ovarian cancer
by: Li Ma, et al.
Published: (2017-02-01)

Chemotherapy-Related Amenorrhea in Breast Cancer: Review of the Main Published Studies, Biomarkers of Ovarian Function and Mechanisms Involved in Ovarian Toxicity
by: Berliere, M., et al.
Published: (2011)

Ovarian Follicular Atresia
by: Townson, David H., et al.
Published: (2012)